on TRANSGENE (EPA:TNG)
Transgene Prepares for Biomed Investor Forum
On January 21, 2025, Transgene, a biotechnology company based in Strasbourg, announced its participation in the next edition of the Biomed Forum conference. This event, which targets institutional investors, will take place on February 4, 2025 in Paris and is organized by AllInvest Securities.
Transgene specializes in the development of cancer immunotherapies using viral vectors. The company is listed on Euronext Paris under the symbol TNG. The participation of the management team in this event demonstrates the company's commitment to informing and attracting potential investors through innovative technologies.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all TRANSGENE news